牛牛提示：$Addex Therapeutics (ADXN.US)$Earnings report will be released before the market opens on November 22nd, investors are urged to pay attention.
How was the previous performance?
$Addex Therapeutics (ADXN.US)$In Q2 2024, revenue was 0.115277 million francs, net income was 12.878632 million francs, and EPS was 9.6 francs.
In Q3 2023, revenue was 0.327733 million francs, net income was -2.61707 million francs, and EPS was -3.6 francs.
Futubull reminder:
1. There is no strict requirement for the division of accounting year for Hong Kong and US listed companies, which is entirely determined by the company itself. Therefore, each financial reporting period can be used as the company's annual report deadline, rather than using the calendar year as the fiscal year.
2. Generally, the company will hold a financial report conference on the above financial report release date or nearby dates. At that time, the company's management will discuss and explain the latest quarterly financial data and operational situation, and communicate with investors, analysts, media, etc.
Investors can participate through offline meetings or online teleconferences, etc.
